+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5518254
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mesenchymal Stem Cells Market grew from USD 3.51 billion in 2023 to USD 3.98 billion in 2024. It is expected to continue growing at a CAGR of 13.63%, reaching USD 8.59 billion by 2030.

These cells are identified by their ability to adhere to plastic surfaces when cultured under specific conditions and by the expression of certain surface markers. MSCs are harvested from various tissues, including bone marrow, adipose tissue, umbilical cord blood, and dental pulp. The major factors driving the expansion of their use include their regenerative potential, immunomodulatory properties, and their use in treating various diseases, such as osteoarthritis, cardiovascular disease, and graft-versus-host disease. Additionally, their potential in emerging regenerative medicine applications and as delivery vehicles for gene therapy has further catalyzed research and industry interest. However, there is a risk of immune rejection and potential for malignant transformation with the use of MSCs. To address these issues, standardization of MSC isolation and culture techniques is critical, as well as the development of robust protocols for in vitro expansion and quality control. Advances in tissue engineering and the development of 3D bioprinting technologies may allow for the construction of complex tissues and organs using MSCs. Additionally, the growing emphasis on personalized medicine is likely to lead to more targeted and effective MSC-based therapies.

Regional Insights

In the Americas, particularly the United States and Canada, there is a robust presence of biotechnology firms engaged in mesenchymal stem cell (MSCs) research and therapy development, supported by significant investment and favorable regulatory pathways for cell therapy products. These countries are major in clinical trials involving MSCs, focusing on applications such as osteoarthritis, wound healing, and graft-versus-host disease, propelled by the FDA's progressive stance on stem cell therapies and advanced healthcare infrastructure. The APAC region, led by countries such as China, Japan, and South Korea, showcases a dynamic and rapidly growing interest in MSCs, with governments actively promoting regenerative medicine as a key area for scientific advancement. APAC companies are investing heavily in scaling up manufacturing capabilities and in establishing international collaborations to enhance both research and clinical application of MSCs. The EMEA region presents a mixed scenario, with European countries adhering to stringent regulatory standards similar to those in the Americas. The European Medicines Agency (EMA) offers a comprehensive regulatory framework that ensures the safety and efficacy of MSC products. Nonetheless, Europe is home to several pioneering companies and research institutions dedicated to stem cell research, with a focus on quality and adherence to Good Manufacturing Practice (GMP) standards.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Mesenchymal Stem Cells Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growth in Mesenchymal Stem Cell-Based Research
  • Rising Geriatric Population Coupled with Growth in Chronic Diseases
  • Continuously Evolving Landscape of Stem Cell Therapies

Market Restraints

  • Lack of Standardized and Regulated Delivery of Stem Cell Therapy

Market Opportunities

  • Emerging Applications of Mesenchymal Stem Cells
  • Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products

Market Challenges

  • Ethical & Safety Issues Associated with Human MSC Therapy

Market Segmentation Analysis

  • Type: Immunological safety and personalized nature of autologous MSCs to make them beneficial for long-term treatments
  • Indication: Substantial research and development activities on MSCs for the treatment of CVDs
  • Source of Isolation: High cell yield and established therapeutic use of bone-marrow derived MSC
  • Application: Benefits of MSCs in disease modeling and drug discovery due to their ability to mimic human diseases and test drug efficacy

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Mesenchymal Stem Cells Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Mesenchymal Stem Cells Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Cellcolabs Announces Partnership With REPROCELL for Research And GMP Grade MSC And MSC Derivatives

Cellcolabs AB forged a strategic partnership with REPROCELL Inc. to enhance global access to high-caliber MSCs and their derivatives, with REPROCELL obtaining exclusive distribution rights in Japan. This partnership further focuses on processing and commercializing products derived from Cellcolabs' MSCs.

PromoCell Launches PromoExQ MSC Growth Medium XF for GMP-Compliant Isolation and Expansion of Mesenchymal Stem Cells

PromoCell has introduced advanced PromoExQ MSC Growth Medium XF, meticulously designed for the GMP-compliant cultivation and proliferation of diverse mesenchymal stem cells (MSCs), empowering cell therapy manufacturing. Crafted to facilitate the consistent development of bone marrow, umbilical cord matrix, and adipose tissue MSCs, the medium demonstrates an impressive population doubling time of under 40 hours, as revealed in studies with human MSCs isolated from bone marrow. Adhering to stringent quality standards, PromoExQ MSC Growth Medium XF is produced in alignment with PromoCell's rigorous EXCiPACT GMP certification, which incorporates the prestigious ISO 9001:2015 framework.

Pluristyx and Stemmatters Announce Partnership to Develop and Manufacture iPSC-derived MSC Banks

Pluristyx and Stemmatters collaborated to propel the evolution of regenerative medicine via iPSC-derived mesenchymal stem cell (iMSC) technologies. Capitalizing on Pluristyx's prowess in iPSC generation and Stemmatters' excellence in stem cell manufacturing and banking, this partnership transits early research into clinical applications.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Mesenchymal Stem Cells Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Mesenchymal Stem Cells Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology, Astellas Pharma Inc., Athersys, Inc., Axol Biosciences Ltd., BrainStorm Cell Therapeutics Inc., Cell Applications, Inc., Celprogen, Inc., Cyagen Biosciences, Inc., Cytori Therapeutics Inc., Genlantis, Inc., Globus Medical, Hope Biosciences, LLC, Lonza Group AG, Merck KGaA, Mesoblast Limited, Neuromics, Pluri Biotech Ltd., PromoCell GmbH, R&D Systems, Inc., ScienCell Research Laboratories, Inc., Smith & Nephew PLC, Stemcell Technologies Inc., Stemedica Cell Technologies, Inc., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Mesenchymal Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

  • Allogeneic
  • Autologous

Indication

  • Bone & Cartilage Repair
  • Cancer
  • Cardiovascular Disease
  • GvHD
  • Inflammatory & Immunological Disease
  • Liver Diseases

Source of Isolation

  • Adipose Tissues
  • Bone Marrow
  • Cord Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Peripheral Blood

Application

  • Disease Modeling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in Mesenchymal Stem Cell-Based Research
5.1.1.2. Rising Geriatric Population Coupled with Growth in Chronic Diseases
5.1.1.3. Continuously Evolving Landscape of Stem Cell Therapies
5.1.2. Restraints
5.1.2.1. Lack of Standardized and Regulated Delivery of Stem Cell Therapy
5.1.3. Opportunities
5.1.3.1. Emerging Applications of Mesenchymal Stem Cells
5.1.3.2. Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products
5.1.4. Challenges
5.1.4.1. Ethical & Safety Issues Associated with Human MSC Therapy
5.2. Market Segmentation Analysis
5.2.1. Type: Immunological safety and personalized nature of autologous MSCs to make them beneficial for long-term treatments
5.2.2. Indication: Substantial research and development activities on MSCs for the treatment of CVDs
5.2.3. Source of Isolation: High cell yield and established therapeutic use of bone-marrow derived MSC
5.2.4. Application: Benefits of MSCs in disease modeling and drug discovery due to their ability to mimic human diseases and test drug efficacy
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Mesenchymal Stem Cells Market, by Type
6.1. Introduction
6.2. Allogeneic
6.3. Autologous
7. Mesenchymal Stem Cells Market, by Indication
7.1. Introduction
7.2. Bone & Cartilage Repair
7.3. Cancer
7.4. Cardiovascular Disease
7.5. GvHD
7.6. Inflammatory & Immunological Disease
7.7. Liver Diseases
8. Mesenchymal Stem Cells Market, by Source of Isolation
8.1. Introduction
8.2. Adipose Tissues
8.3. Bone Marrow
8.4. Cord Blood
8.5. Fallopian Tube
8.6. Fetal Liver
8.7. Lung
8.8. Peripheral Blood
9. Mesenchymal Stem Cells Market, by Application
9.1. Introduction
9.2. Disease Modeling
9.3. Drug Development & Discovery
9.4. Stem Cell Banking
9.5. Tissue Engineering
9.6. Toxicology Studies
10. Americas Mesenchymal Stem Cells Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Mesenchymal Stem Cells Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Mesenchymal Stem Cells Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Cellcolabs Announces Partnership With REPROCELL for Research And GMP Grade MSC And MSC Derivatives
13.3.2. PromoCell Launches PromoExQ MSC Growth Medium XF for GMP-Compliant Isolation and Expansion of Mesenchymal Stem Cells
13.3.3. Pluristyx and Stemmatters Announce Partnership to Develop and Manufacture iPSC-derived MSC Banks
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. MESENCHYMAL STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. MESENCHYMAL STEM CELLS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MESENCHYMAL STEM CELLS MARKET DYNAMICS
FIGURE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MESENCHYMAL STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY & IMMUNOLOGICAL DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY & IMMUNOLOGICAL DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 84. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 85. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 86. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 87. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 92. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 93. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 94. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 95. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 120. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 128. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 129. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 130. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 131. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 136. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 137. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 138. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 139. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 144. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 145. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 146. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 147. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 152. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 153. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 154. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 155. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 162. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 163. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 168. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 169. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 170. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 171. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 176. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 177. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 178. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 179. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 186. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 187. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 194. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 195. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 200. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 201. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 202. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 203. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 208. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 209. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 210. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 211. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 223. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 226. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 227. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 228. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 229. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 236. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 237. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 242. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 243. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 244. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 245. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 250. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 251. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 252. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 253. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 258. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 259. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 260. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 261. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 266. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 267. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 268. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 269. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 274. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 275. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 276. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 277. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 282. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 283. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 284. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 285. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 289. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 290. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 291. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 292. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 293. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 296. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 297. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 298. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 299. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 300. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 301. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 304. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 305. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 306. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 307. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 308. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 309. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 312. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 313. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 314. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 315. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 316. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 317. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 320. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 321. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 322. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 323. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 324. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 325. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 328. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 330. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2023 (USD MILLION)
TABLE 332. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2024-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 336. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 338. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATIO

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AMS Biotechnology
  • Astellas Pharma Inc.
  • Athersys, Inc.
  • Axol Biosciences Ltd.
  • BrainStorm Cell Therapeutics Inc.
  • Cell Applications, Inc.
  • Celprogen, Inc.
  • Cyagen Biosciences, Inc.
  • Cytori Therapeutics Inc.
  • Genlantis, Inc.
  • Globus Medical
  • Hope Biosciences, LLC
  • Lonza Group AG
  • Merck KGaA
  • Mesoblast Limited
  • Neuromics
  • Pluri Biotech Ltd.
  • PromoCell GmbH
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Smith & Nephew PLC
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies, Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.98 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.59 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal

Related Topics

Related Reports

Global Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report by Product & Services, Workflow Type, Type, Source Of Isolation, Indication, Application, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report by Product & Services, Workflow Type, Type, Source Of Isolation, Indication, Application, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Mesenchymal Stem Cells Global Market Report 2024 - Product Image

Mesenchymal Stem Cells Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Mesenchymal Stem Cells Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Mesenchymal Stem Cells Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 172 Pages
  • Global
From
Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Mesenchymal Stem Cells (MSC) - Global Strategic Business Report - Product Image

Mesenchymal Stem Cells (MSC) - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From

About the Mesenchymal Stem Cell Market

The Mesenchymal Stem Cell (MSC) market is a rapidly growing sector of the genomics industry. MSCs are multipotent cells that can differentiate into a variety of cell types, including bone, cartilage, and fat. They are used in regenerative medicine, tissue engineering, and drug discovery. MSCs are also being studied for their potential to treat a variety of diseases, including cancer, autoimmune disorders, and cardiovascular diseases. The MSC market is driven by advances in genomics technology, such as gene editing and sequencing, which have enabled researchers to better understand the biology of MSCs and develop new therapeutic applications. Additionally, the increasing demand for personalized medicine and the growing awareness of the potential of MSCs to treat a variety of diseases are driving the growth of the MSC market. Some of the major companies in the MSC market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, STEMCELL Technologies, and Cellular Dynamics International. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.